- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Moe Alsumidaie
Articles
How Emerging Biopharmas Can Obtain VC Funding
Ken Shimokawa, Founder and General Partner of G4S Capital, shares insights into what venture capitalists look for when evaluating emerging biopharmaceutical opportunities.
Insights: How Biopharma is Applying AI and Machine Learning
Gabe Musso, Chief Scientific Officer of BioSymetrics, talks about insights around how AI and ML are being used in biopharma.
Patient Centricity by Prodrug Design
Travis Mickle, CEO of KemPharm, talks about his company’s use of prodrugs, the business opportunities prodrugs represent, and how prodrugs are helping to improve patient centricity.
Biopharma Tackles Antimicrobial-Resistant Fungi
SCYNEXIS CEO, Marco Taglietti, talks about efforts to help advance fungal disease treatments.
One CEO, Two Pharma Companies
In this Q&A, Hugh McTavish, CEO of Squarex and IGF-Oncology, shares with Pharm Exec his perspectives on running both enterprises and the medical products each is developing.
Post-Traumatic Stress Disorder in Focus
In this Q&A, Seth Lederman, CEO of Tonix Pharmaceuticals, shares key learnings for Tonix’s recent clinical trials and how they are using their expertise to provide relief to unmet patient populations.